omniture
LUNIT INC

Latest News

Lunit to Present Six AI Studies at AACR 2026 Highlighting Advances in Precision Oncology and Real-World Clinical Application

Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clini...

2026-04-18 03:00 8581

Lunit Surpasses 330+ Sites and 1M Annual Screenings as Breast Imaging AI Moves into Clinical Practice

Lunit highlights enterprise AI adoption and FDA-cleared advancements at SBI 2026 SEOUL, South Korea...

2026-04-16 20:00 3950

Lunit to Be Featured in 21 AI Imaging Studies on Breast Cancer and Lung Disease at ECR 2026

* 13 oral presentations included, reaffirming the clinical value of AI-based medical image analys...

2026-03-04 22:00 6407

Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Translational Oncology Research

Collaboration to leverage Lunit SCOPE IO ® and SCOPE universal IHC® (uIHC) digital pathology produc...

2025-12-15 22:00 3204

Lunit Submits 510(k) Application for Image-Based Breast Cancer Risk Prediction Model

Submission marks a key regulatory milestone toward bringing SEER-calibrated, imaging-based risk ass...

2025-12-08 22:00 1956

Lunit to Highlight New AI Evidence in Cancer Screening and Breast Density-Driven Risk Modeling at RSNA 2025

Eight oral presentations and six posters demonstrate advances in mammography, DBT performance, and ...

2025-12-02 22:10 4669

Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research

DURHAM, N.C. and SEOUL, South Korea, Nov. 20, 2025 /PRNewswire/ -- Lunit, a leading provider of AI ...

2025-11-20 13:01 3526

Lunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 2025

Studies reveal how the Lunit SCOPE® suite identifies immunotherapy-responsive subtypes, standardize...

2025-11-07 22:05 4094

Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence

The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, ...

2025-11-07 08:14 1884

Volpara Earns ACR® Learning Network Vendor Partner Designation

LYNNWOOD, Wash., Oct. 16, 2025 /PRNewswire/ -- Volpara Health has qualified for the American Colleg...

2025-10-16 21:00 1878

Lunit AI Predicts Immunotherapy Outcome in Colorectal, Kidney, and Lung Cancer at ESMO 2025

AI-powered histopathology demonstrates predictive value for immunotherapy outcomes in pMMR mCRC, ad...

2025-10-14 21:00 1479

Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials

SEOUL, South Korea and MONTREAL, Sept. 24, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading pr...

2025-09-24 21:00 2604

Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine

Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize b...

2025-09-22 21:00 2466

Lunit Showcases AI-Powered Cancer Ecosystem at APEC High-Level Meeting on Health and the Economy and World Bio Summit 2025

Lunit highlights global leadership in cancer AI alongside world health experts with dedicated APEC ...

2025-09-16 21:00 5561

Lunit Awarded Major National Tender in France, Expanding Access to Breast AI in Public Hospitals

Framework agreement with UniHA enables access to Lunit's breast AI solutions across 1,500+ French p...

2025-09-11 21:00 2440

Lunit Selected as Exclusive AI Partner for Spain's Valencian Community Breast Screening Program

Milestone European deployment underscores growing global trust in Lunit's AI for population-wide br...

2025-09-02 21:00 2736

Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis

SEOUL, South Korea, July 2, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI fo...

2025-07-02 21:00 2683

Lunit Launches Enhanced Lunit INSIGHT CXR4, Secures CE MDR Certification for Expanded AI Capabilities

Next-generation AI solution introduces new clinical features and broader disease detection for ches...

2025-05-28 21:00 2999

Lunit Highlights AI's Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies

SEOUL, South Korea, May 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI fo...

2025-05-26 21:00 2895

Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition

Building on Volpara's breast health expertise, Lunit strengthens its U.S. presence—now delivering A...

2025-05-19 21:00 2953
12345 ... 8